首页> 外国专利> Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

Recombinant multiple domain fusion protein mitogens and use thereof for inducing enhancement or repression of antigen-specific immunity

机译:重组多域融合蛋白促细胞分裂剂及其在诱导增强或抑制抗原特异性免疫中的用途

摘要

The invention relates to cell stimulatory fusion proteins and DNA sequences, vectors comprising at least two agonists of TNF/TNFR super family, immunoglobulin super family, cytokine family proteins and optional antigen combination. Instructions for use of these proteins and DNA constructs as immune adjuvants and vaccines for treatment of various chronic diseases such as viral infection are also provided. Additionally, the use of these protein and DNA constructs as immune suppressant for treatment of various chronic diseases, such as autoimmunity and organ transplant rejection, is also illustrated.
机译:本发明涉及细胞刺激融合蛋白和DNA序列,包含至少两种TNF / TNFR超家族,免疫球蛋白超家族,细胞因子家族蛋白和任选的抗原组合的激动剂的载体。还提供了使用这些蛋白质和DNA构建体作为免疫佐剂和疫苗来治疗各种慢性疾病(如病毒感染)的说明。另外,还说明了这些蛋白质和DNA构建体作为免疫抑制剂用于治疗各种慢性疾病,例如自身免疫和器官移植排斥的用途。

著录项

  • 公开/公告号US10583181B2

    专利类型

  • 公开/公告日2020-03-10

    原文格式PDF

  • 申请/专利权人 ATSUO OCHI;

    申请/专利号US201815893644

  • 发明设计人 ATSUO OCHI;

    申请日2018-02-11

  • 分类号C12N5;C12N15/09;C12N15/63;C07K14/525;C07K14/705;C07K14/725;C07K14/735;C07K16/18;C07K19;A61K39;A61K39/145;A61K39/39;C07K14/715;A61K39/12;C07K14/48;A61K38/16;A61K38/18;A61K38/19;A61K39/395;A61K38/17;

  • 国家 US

  • 入库时间 2022-08-21 11:26:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号